Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

Ehlers-Danlos syndrome VIII with novel C1R variant accompanying white matter changes

  • Seo, Go Hun (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Yoon-Myung (Department of Pediatrics, Jeju National University School of Medicine) ;
  • Ghang, Byeongzu (Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Gu-Hwan (Medical Genetics Center, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Beom Hee (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2018.09.19
  • Accepted : 2018.10.15
  • Published : 2019.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Ehlers-Danlos syndrome (EDS) VIII is an autosomal dominant inherited connective tissue disorder characterized by intractable periodontal inflammation, absence of gingiva, pretibial plaques, skin hyperextensibility, joint hypermobility, and tissue fragility with onset in the childhood or adolescence. In a recent report, heterozygous variants of the C1R or C1S related to the classical complement pathway were identified in families with history of EDS VIII. The current report describes a Korean 34-year-old female carrying a novel missense variant of C1R c.925T>G (p.Cys309Gly) and exhibiting early severe periodontitis, skin fragility, and joint hypermobility. The patient also had frontal, parietal, and temporal white matter brain lesions without definite vascular abnormalities on brain magnetic resonance imaging, which have not been surveyed meticulously in EDS VIII. Considering the genetic alteration of classic complement pathways in this condition, it is necessary to carefully observe multisystemic inflammation processes such as changes in brain white matter.

Keywords

References

  1. Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017;175:8-26. https://doi.org/10.1002/ajmg.c.31552
  2. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998;77:31-7. https://doi.org/10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O
  3. Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, et al. The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet 2017;175:70-115. https://doi.org/10.1002/ajmg.c.31550
  4. Stewart RE, Hollister DW, Rimoin DL. A new variant of Ehlers-Danlos syndrome: an autosomal dominant disorder of fragile skin, abnormal scarring, and generalized periodontitis. Birth Defects Orig Artic Ser 1977;13:85-93.
  5. Rahman N, Dunstan M, Teare MD, Hanks S, Douglas J, Coleman K, et al. Ehlers-Danlos syndrome with severe early-onset periodontal disease (EDS-VIII) is a distinct, heterogeneous disorder with one predisposition gene at chromosome 12p13. Am J Hum Genet 2003;73:198-204. https://doi.org/10.1086/376416
  6. Reinstein E, DeLozier CD, Simon Z, Bannykh S, Rimoin DL, Curry CJ. Ehlers-Danlos syndrome type VIII is clinically heterogeneous disorder associated primarily with periodontal disease, and variable connective tissue features. Eur J Hum Genet 2013;21:233-6. https://doi.org/10.1038/ejhg.2012.132
  7. Kapferer-Seebacher I, Pepin M, Werner R, Aitman TJ, Nordgren A, Stoiber H, et al. Periodontal Ehlers-Danlos syndrome is caused by mutations in C1R and C1S, which encode subcomponents C1r and C1s of complement. Am J Hum Genet 2016;99:1005-14. https://doi.org/10.1016/j.ajhg.2016.08.019
  8. Spranger S, Spranger M, Kirchhof K, Steinmann B. Ehlers-Danlos syndrome type VIII and leukodystrophy. Am J Med Genet 1996;66:239-40. https://doi.org/10.1002/(SICI)1096-8628(19961211)66:2<239::AID-AJMG23>3.0.CO;2-T
  9. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24. https://doi.org/10.1038/gim.2015.30
  10. Moore MM, Votava JM, Orlow SJ, Schaffer JV. Ehlers-Danlos syndrome type VIII: periodontitis, easy bruising, marfanoid habitus, and distinctive facies. J Am Acad Dermatol 2006;55:S41-5. https://doi.org/10.1016/j.jaad.2006.02.024
  11. George SM, Vandersteen A, Nigar E, Ferguson DJ, Topham EJ, Pope FM. Two patients with Ehlers-Danlos syndrome type VIII with unexpected hoarseness. Clin Exp Dermatol 2016;41:771-4. https://doi.org/10.1111/ced.12911
  12. Cooper NR. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 1985;37:151-216. https://doi.org/10.1016/S0065-2776(08)60340-5
  13. Shen Y, Lue L, Yang L, Roher A, Kuo Y, Strohmeyer R, et al. Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci Lett 2001;305:165-8. https://doi.org/10.1016/S0304-3940(01)01842-0
  14. Brink BP, Veerhuis R, Breij EC, van der Valk P, Dijkstra CD, Bo L. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005;64:147-55. https://doi.org/10.1093/jnen/64.2.147